Studies on the relation of chemical structure to glycogenolytic activity in the brain.
D000588:Amines / Q000494:pharmacology; D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001554:Benzene / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects*; D003913:Dextroamphetamine / Q000494:pharmacology; D004053:Diethylpropion / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004809:Ephedrine / Q000494:pharmacology; D005277:Fenfluramine / Q000494:pharmacology; D006003:Glycogen / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008635:Mescaline / Q000494:pharmacology; D051379:Mice; D010624:Phenelzine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000494:pharmacology; D011407:Propane / Q000494:pharmacology; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013997:Time Factors; D014363:Tryptamines / Q000494:pharmacology
D000588:Amines; D010627:Phenethylamines; D014363:Tryptamines; D005277:Fenfluramine; D010665:Phenylpropanolamine; D006003:Glycogen; D000661:Amphetamine; D004809:Ephedrine; D001554:Benzene; D010624:Phenelzine; D004053:Diethylpropion; D008635:Mescaline; D011407:Propane; D003913:Dextroamphetamine